Edwards Lifesciences (EW) Tops Q2 EPS by 5c, Offers FY and Q3 Guidance
Tweet Send to a Friend
Edwards Lifesciences (NYSE: EW) reported Q2 EPS of $1.38, $0.05 better than the analyst estimate of $1.33. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
